Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDASCENTAGE PHARMA GROUP INTERNATIONAL Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2025 | 1 | -$3.06 | -$3.06 | -$3.06 |
| Q3 2025 | 1 | -$1.61 | -$1.61 | -$1.61 |
| Q1 2026 | 1 | $0.12 | $0.12 | $0.12 |
| Q2 2026 | 1 | $0.12 | $0.12 | $0.12 |
| Q3 2026 | 1 | $0.12 | $0.12 | $0.12 |
| Q4 2026 | 1 | $0.12 | $0.12 | $0.12 |
| Q1 2027 | 1 | -$1.50 | -$1.50 | -$1.50 |
| Q2 2027 | 1 | -$1.54 | -$1.54 | -$1.54 |
| Q3 2027 | 1 | -$1.54 | -$1.54 | -$1.54 |
ASCENTAGE PHARMA GROUP INTERNATIONAL Earnings Date And Information
ASCENTAGE PHARMA GROUP INTERNATIONAL last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 233.70 M for the quarter and had revenue of 980.65 M for the year. ASCENTAGE PHARMA GROUP INTERNATIONAL has generated $-1 earnings per share over the last year ($-1.34 diluted earnings per share) and currently has a price-to-earnings ratio of -62.93. ASCENTAGE PHARMA GROUP INTERNATIONAL has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 1st, 2026 based on prior year's report dates.
ASCENTAGE PHARMA GROUP INTERNATIONAL Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 2025 | N/A | -$1.73 | N/A | $233.70 M | $233.70 M |
| 12/31/2024 | Q4 2024 | N/A | -$1.82 | N/A | N/A | $156.90 M |
| 06/30/2024 | Q2 2024 | N/A | $0.56 | N/A | N/A | $823.75 M |
| 12/31/2023 | Q4 2023 | N/A | -$1.80 | N/A | N/A | $79.28 M |
| 06/30/2023 | Q2 2023 | N/A | -$11.32 | N/A | N/A | $142.70 M |
| 12/31/2022 | Q4 2022 | N/A | -$6.70 | N/A | N/A | $104.86 M |
| 06/30/2022 | Q2 2022 | N/A | -$6.70 | N/A | N/A | $104.86 M |
| 12/31/2021 | Q4 2021 | N/A | -$6.14 | N/A | N/A | $2.16 M |
| 06/30/2021 | Q2 2021 | N/A | -$6.14 | N/A | N/A | $2.16 M |
| 12/31/2020 | Q4 2020 | N/A | -$6.28 | N/A | N/A | $6.23 M |
| 06/30/2020 | Q2 2020 | N/A | -$6.28 | N/A | N/A | $6.23 M |
| 12/31/2019 | Q4 2019 | N/A | -$14.00 | N/A | N/A | $7.26 M |
| 06/30/2019 | Q2 2019 | N/A | -$14.00 | N/A | N/A | $7.26 M |
| 12/31/2018 | Q4 2018 | N/A | -$6.63 | N/A | N/A | $6.67 M |
| 06/30/2018 | Q2 2018 | N/A | -$0.04 | N/A | N/A | $141.22 K |
| 12/31/2017 | Q4 2017 | N/A | -$2.22 | N/A | N/A | $6.05 M |
| 06/30/2017 | Q2 2017 | N/A | -$0.07 | N/A | N/A | $275.25 K |
| 12/31/2016 | Q4 2016 | N/A | -$1.04 | N/A | N/A | $3.83 M |
| 06/30/2016 | Q2 2016 | N/A | -$1.04 | N/A | N/A | $3.83 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ASCENTAGE PHARMA GROUP INTERNATIONAL Earnings: FAQ's
ASCENTAGE PHARMA GROUP INTERNATIONAL has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 1st, 2026 based offlast year's report dates.
The conference call for ASCENTAGE PHARMA GROUP INTERNATIONAL's latest earnings report can be listened to online.
The conference call transcript for ASCENTAGE PHARMA GROUP INTERNATIONAL's latest earnings report can be read online.
ASCENTAGE PHARMA GROUP INTERNATIONAL (:AAPG) has a recorded annual revenue of $980.65 M.
ASCENTAGE PHARMA GROUP INTERNATIONAL (:AAPG) has a recorded net income of $-405,433,000.ASCENTAGE PHARMA GROUP INTERNATIONAL has generated $-1.34 earnings per share over the last four quarters.
ASCENTAGE PHARMA GROUP INTERNATIONAL (:AAPG) has a price-to-earnings ratio of -62.93 and price/earnings-to-growth ratio is 0.35.